Ipamorelin dosage
What is Ipamorelin?
Ipamorelin is a synthetic peptide made of five amino acids, first described in the scientific literature in 1998. It belongs to a group called growth hormone secretagogues, compounds that prompt the body to release its own growth hormone. It was later tested by Helsinn Therapeutics as a possible treatment to speed bowel recovery after surgery, but it was never approved.
How it works
Ipamorelin mimics ghrelin, a natural hormone, and acts on the same type of receptor to trigger growth hormone release from the pituitary gland. In animal studies it released growth hormone without significantly raising the stress hormones ACTH and cortisol, which is why its developers called it selective.
What the evidence shows
Human evidence is limited to early studies. In healthy male volunteers given short infusions, ipamorelin produced a single burst of growth hormone that peaked in under an hour and then faded, and the drug had a half-life of about 2 hours. A Phase 2 trial in 117 bowel-surgery patients tested intravenous ipamorelin against placebo; the time until patients could tolerate a solid meal was not significantly different (25.3 versus 32.6 hours, p = 0.15). A second, larger Phase 2 trial of 320 patients was completed in 2014, but no results are posted on the trial registry. There are no completed human trials of ipamorelin for muscle gain, fat loss, sleep or aging, and no long-term safety data.
Reported side effects
- In the surgical trial, side effects occurred at similar rates with ipamorelin (87.5%) and placebo (94.8%), and the authors called it well tolerated
- Serious adverse events, including death, in a published study of intravenous ipamorelin, as reported by the FDA
- Possible immune reaction to the peptide when injected, flagged by the FDA
- Effects reported for growth hormone-stimulating peptides as a group: fluid retention, joint and muscle pain, blood sugar changes, appetite changes and injection-site reactions
Cautions
- Long-term safety is unknown; human studies were short and involved hospital patients or healthy volunteers.
- The FDA says it lacks enough safety information on injection routes other than intravenous to judge the risk of harm.
- Raising growth hormone also raises IGF-1, a growth factor; reviewers describe a theoretical concern about promoting cell growth.
- Products sold as research compounds have uncertain purity, dose consistency and sterility.
Legal and regulatory status
Ipamorelin is not an FDA-approved drug. The FDA lists ipamorelin acetate as a bulk substance that raises significant safety risks in compounding (category 2 for outsourcing facilities, added September 2023). USADA lists ipamorelin as prohibited in sport at all times.
Common questions
Is ipamorelin FDA approved?
No. It reached Phase 2 trials for bowel recovery after surgery, and the published trial found no significant benefit over placebo.
Does ipamorelin raise cortisol?
In animal studies it did not significantly raise ACTH or cortisol, unlike the older peptides GHRP-6 and GHRP-2, and a review of the early human data reports no significant effect on other pituitary or adrenal hormones. Those were short studies, so the effect of long-term use is unknown.
What did human trials of ipamorelin actually show?
Healthy volunteers had a short-lived rise in growth hormone. The published trial in bowel-surgery patients found no statistically significant improvement over placebo, and no trial has tested it for body composition or anti-aging.
Sources
- European Journal of Endocrinology (1998), PubMed record 9849822: Ipamorelin, the first selective growth hormone secretagogue
- Pharmaceutical Research (1999), PubMed record 10496658: Ipamorelin in human volunteers
- International Journal of Colorectal Disease (2014), PubMed record 25331030: Ipamorelin for postoperative ileus
- ClinicalTrials.gov: registered ipamorelin studies
- FDA: Certain bulk drug substances for use in compounding that may present significant safety risks
- Frontiers in Endocrinology (2026): Performance-enhancing peptides modulating the GH-IGF1 axis
- USADA: Anthony McCauley accepts doping sanction
Ipamorelin reviews and Q&A
No reviews or questions yet. Be the first.
Get the printable dosing chart
All 50 peptides on a few pages, as a PDF. We’ll also email you when a peptide’s approval status or dosing changes.
More in Growth hormone
Stacks that include Ipamorelin
Compare Ipamorelin
Reference only, not medical advice. Doses marked FDA-approved come from the US prescribing label. Doses marked Not approved are ranges reported from small studies or community use and have not been established as safe or effective in humans. Check anything here with a licensed clinician before acting on it. Read the full disclaimer.